Intuitive Surgical, Inc. $ISRG Shares Purchased by Capital Analysts LLC

Posted by Brenda Bartman on Sep 11th, 2026

Capital Analysts LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 324.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,354 shares of the medical equipment provider’s stock after buying an additional 1,800 shares during the quarter. Capital Analysts LLC’s holdings in Intuitive Surgical were worth $936,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Main Street Group LTD acquired a new stake in shares of Intuitive Surgical in the 1st quarter worth $30,000. Compass Financial Management LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $30,000. Vermillion Wealth Management Inc. boosted its position in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares during the last quarter. Motiv8 Investments LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $34,000. Finally, Evergreen Advisors LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $35,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the director owned 251 shares in the company, valued at approximately $95,129. This trade represents a 61.44% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. The trade was a 6.99% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 11,256 shares of company stock valued at $4,475,079. 0.60% of the stock is owned by insiders.

Intuitive Surgical Trading Up 2.0%

Shares of ISRG opened at $360.46 on Friday. The company’s 50-day moving average price is $377.41 and its 200 day moving average price is $424.21. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market cap of $127.34 billion, a P/E ratio of 41.29, a price-to-earnings-growth ratio of 2.67 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same quarter last year, the firm posted $1.81 earnings per share. Intuitive Surgical’s revenue was up 18.4% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.85 earnings per share for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: A meta-analysis found that da Vinci robotic-assisted surgery produced statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The results reinforce the clinical value of Intuitive’s platform and could support further hospital adoption. Intuitive reports positive meta-analysis data
Positive Sentiment: BTIG reiterated its Buy rating and set a $469 price target, signaling considerable potential upside. Broader analyst coverage remains favorable, with the stock described as trading at its cheapest valuation in roughly a decade. Recent earnings also showed strong execution, including 18.4% year-over-year revenue growth and an earnings beat. BTIG reiterates Buy rating
Neutral Sentiment: Intuitive Surgical presented at the Wells Fargo Healthcare Conference. Investors are focused on management’s commentary regarding procedure trends, guidance, competition, costs and the long-term opportunity for robotic surgery. Wells Fargo Healthcare Conference transcript
Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day short-interest ratio, suggesting no measurable short positioning in the supplied data; however, the figures appear anomalous and should not be treated as a meaningful trading signal.
Negative Sentiment: EVP Mark Brosius disclosed sales totaling 69 shares at approximately $350.20 and $361.23 under a pre-arranged Rule 10b5-1 plan. The transactions are small relative to his remaining holdings and are not necessarily bearish, but continued insider selling provides little additional support for the shares. Intuitive Surgical EVP stock sale
Negative Sentiment: Investors remain concerned about slower U.S. procedure growth, rising costs, competitive pressure and the possibility that GLP-1 drugs could affect procedure volumes. Options markets also indicate that substantial volatility may persist after the stock’s steep decline from its 52-week high. ISRG volatility outlook

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research note on Tuesday, June 2nd. UBS Group assumed coverage on shares of Intuitive Surgical in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $500.00 price target for the company. TD Cowen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, July 28th. JPMorgan Chase & Co. reduced their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research report on Friday, July 17th. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.

Read Our Latest Report on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.